A phase IIa randomized clinical study testing GNbAC1, a humanized monoclonal antibody against the envelope protein of multiple sclerosis associated endogenous retrovirus in multiple sclerosis patients - A twelve month follow-up

导出原文传递

翻译打印收藏纠错

作者： Derfuss, Tobias ^[1] ; Curtin, Francois ^[2] ; Guebelin, Claudia ^[3] ; Bridel, Claire ^[4] ; Rasenack, Maria ^[5] ; Matthey, Alain ^[6] ; Du Pasquier, Renaud ; Schluep, Myriam ; Desmeules, Jules ; Lang, Alois B. ; Perron, Herve ; Faucard, Raphael ; Porchet, Herve ; Hartung, Hans-Peter ; Kappos, Ludwig ; Lalive, Patrice H.

作者单位： Univ Basel Hosp, Dept Neurol, CH-4031 Basel, Switzerland ^[1] Univ Hosp Geneva, Unit Neuroimmunol & Multiple Sclerosis, Div Neurol, Dept Clin Neurosci, CH-1211 ^[2] Univ Dusseldorf, Dept Neurol, D-40225 Dusseldorf, Germany ^[3] Univ Hosp Geneva, Div Pharmacol & Toxicol, CH-1214 Geneva, Switzerland ^[4] Univ Lausanne Hosp, Dept Neurol, CH-1011 Lausanne, Switzerland ^[5] GeNeuro SA, CH-1228 Geneva, Switzerland ^[6]

关键词 Multiple sclerosis Human endogenous retrovirus Monoclonal antibody Clinical trial Safety

发布时间 2015-09-26

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交